The American Heart Association released on Jul. 21 a scientific statement suggesting that habitual coffee consumption is associated with lower risks of several cardiovascular outcomes, though it does not confirm a protective effect of caffeine itself.
Published in the journal Circulation, the statement reviews evidence from observational studies linking coffee intake with different risk patterns for hypertension, atrial fibrillation, type 2 diabetes, stroke, and heart failure. The lowest risk levels vary by condition. However, high doses of caffeine—especially from energy drinks—may cause harm for individuals with severe hypertension or heightened sensitivity to caffeine.
Researchers present clinical evidence connecting caffeine consumption to cardiovascular diseases and discuss possible molecular mechanisms. They note that most studies show a J-shaped association between natural caffeine intake and hypertension: one to three cups daily may increase risk, while higher intakes trend toward lower risk. Genetic analyses suggest people who metabolize caffeine more slowly may have lower blood pressure but caution that high intake could increase risks for certain groups.
The review finds no clear link between caffeine and lipid profiles but cites trials showing unfiltered coffee can raise LDL cholesterol due to cafestol content rather than caffeine itself. Prospective cohort studies indicate either no association or reduced risk of heart failure and coronary artery disease among regular coffee drinkers; two to three cups per day appears optimal for coronary artery disease, while four cups daily is linked to the lowest heart failure risk.
Observational research also suggests regular caffeinated coffee reduces atrial fibrillation risk but may raise premature ventricular beats frequency. In one randomized trial involving patients scheduled for elective cardioversion due to atrial fibrillation, consuming caffeinated coffee was tied to a 39% reduction in recurrent episodes. Decaffeinated coffee has been associated with reduced coronary artery disease and ischemic stroke risks in some cohorts, implying noncaffeine components may contribute benefits.
The authors conclude that habitual consumption of three to five cups of coffee (up to 400 mg/day of caffeine) is generally safe for adults and may be linked with lower cardiovascular disease risks. However, they stress current findings are mostly based on observational data about coffee—not pure caffeine—and call for more randomized controlled trials separating effects of individual food components.
